Seeking Alpha

Wunderlich bumps PT on Symmetry Medical, sees 6% Implant and Cases growth

  • A PT hike to $11 from $10 at Wunderlich Securities may be helping Symmetry Medical shares (SMA +2.8%) higher.
  • Analyst James Terwilliger, which has a Buy rating on the name, believes 2014 revenue growth will be driven by a 6% boost in the Implant and Cases product lines.
  • On the balance sheet side, Terwilliger postulates that "management will remain focused on reducing debt levels."

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector